연구동향 분석

Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma

박중원 성진실 이익재 장홍석 김진희 최영민 계철승 김철용 지의규 유정일 윤상민 김태현 박희철 김종훈 김미숙 2014년

논문상세정보
인용/피인용
' Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • hepatocellular carcinoma
  • multicenterstudy
  • portal vein
  • radiotherapy
  • validation
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,327 0

0.0%

' Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma' 의 참고문헌

  • Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study
    Carr BI Hepatol Int 4 : 396 ~ 405 [2010]
  • Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study
    Carr BI Hepatol Int 4 396-405 [2010]
  • Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Meng MB Radiother Oncol 92 : 184 ~ 194 [2009]
  • Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Meng MB Radiother Oncol 92 184-194 [2009]
  • Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma
    Kim DY Cancer 103 : 2419 ~ 2426 [2005]
  • Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma
    Kim DY Cancer 103 2419-2426 [2005]
  • Survival model predictive accuracy and ROC curves
    Heagerty PJ Biometrics 61 : 92 ~ 105 [2005]
  • Survival model predictive accuracy and ROC curves
    Heagerty PJ Biometrics 61 92-105 [2005]
  • Sorafenib in advanced hepatocellular carcinoma
    Llovet JM N Engl J Med 359 : 378 ~ 390 [2008]
  • Sorafenib in advanced hepatocellular carcinoma
    Llovet JM N Engl J Med 359 378-390 [2008]
  • Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein : long-term patient outcomes
    Yoon SM Int J Radiat Oncol Biol Phys 82 : 2004 ~ 2011 [2012]
  • Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein : long-term patient outcomes
    Yoon SM Int J Radiat Oncol Biol Phys 82 2004-2011 [2012]
  • Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis
    Inarrairaegui M J Vasc Interv Radiol 21 : 1205 ~ 1212 [2010]
  • Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis
    Inarrairaegui M J Vasc Interv Radiol 21 1205-1212 [2010]
  • Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma
    Burgmans MC Cardiovasc Intervent Radiol 35 : 1519 ~ 1523 [2012]
  • Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma
    Burgmans MC Cardiovasc Intervent Radiol 35 1519-1523 [2012]
  • Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
    Kudo M J Gastroenterol 38 : 207 ~ 215 [2003]
  • Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
    Kudo M J Gastroenterol 38 207-215 [2003]
  • Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
    유정일 Journal of Korean Medical Science 26 (8) : 1014 ~ 1022 [2011]
  • Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
    유정일 Journal of Korean Medical Science 26 8 1014-1022 [2011]
  • Prognosis of hepatocellular carcinoma : the BCLC staging classification
    Llovet JM Semin Liver Dis 19 : 329 ~ 338 [1999]
  • Prognosis of hepatocellular carcinoma : the BCLC staging classification
    Llovet JM Semin Liver Dis 19 329-338 [1999]
  • Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials
    Llovet JM Hepatology 29 : 62 ~ 67 [1999]
  • Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials
    Llovet JM Hepatology 29 62-67 [1999]
  • Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients
    Okuda K Cancer 56 : 918 ~ 928 [1985]
  • Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients
    Okuda K Cancer 56 918-928 [1985]
  • Modified RECIST(mRECIST)assessment for hepatocellular carcinoma
    Lencioni R Semin Liver Dis 30 : 52 ~ 60 [2010]
  • Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
    Lencioni R Semin Liver Dis 30 52-60 [2010]
  • Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis
    Katamura Y J Gastroenterol 44 : 492 ~ 502 [2009]
  • Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis
    Katamura Y J Gastroenterol 44 492-502 [2009]
  • Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus
    Peng ZW Cancer 118 : 4725 ~ 4736 [2012]
  • Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus
    Peng ZW Cancer 118 4725-4736 [2012]
  • Efron-type measures of prediction error for survival analysis
    Gerds TA Biometrics 63 : 1283 ~ 1287 [2007]
  • Efron-type measures of prediction error for survival analysis
    Gerds TA Biometrics 63 1283-1287 [2007]
  • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    Cheng AL Lancet Oncol 10 : 25 ~ 34 [2009]
  • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    Cheng AL Lancet Oncol 10 25-34 [2009]
  • Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients
    Leung TW Cancer 94 : 1760 ~ 1769 [2002]
  • Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients
    Leung TW Cancer 94 1760-1769 [2002]
  • Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma
    Kasai K Int J Clin Oncol 16 : 221 ~ 229 [2011]
  • Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma
    Kasai K Int J Clin Oncol 16 221-229 [2011]
  • American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update
    Bruix J Hepatology 53 : 1020 ~ 1022 [2011]
  • American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update
    Bruix J Hepatology 53 1020-1022 [2011]
  • AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement
    Henderson JM HPB (Oxford) 5 : 243 ~ 250 [2003]
  • AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement
    Henderson JM HPB (Oxford) 5 243-250 [2003]
  • A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators
    Hepatology 28 : 751 ~ 755 [1998]
  • A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators
    Hepatology 28 751-755 [1998]
  • A new look at statistical model identification
    Akaike H IEEE Trans Automat Contr 19 : 716 ~ 723 [1974]
  • A new look at statistical model identification
    Akaike H IEEE Trans Automat Contr 19 716-723 [1974]
  • A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus
    Zeng ZC Int J Radiat Oncol Biol Phys 61 : 432 ~ 443 [2005]
  • A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus
    Zeng ZC Int J Radiat Oncol Biol Phys 61 432-443 [2005]